Ocugen Inc. (OCGN): Price and Financial Metrics


Ocugen Inc. (OCGN): $1.33

0.06 (+4.72%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add OCGN to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

OCGN Stock Price Chart Interactive Chart >

Price chart for OCGN

OCGN Price/Volume Stats

Current price $1.33 52-week high $4.53
Prev. close $1.27 52-week low $1.09
Day low $1.28 Volume 10,277,805
Day high $1.40 Avg. volume 6,468,095
50-day MA $1.35 Dividend yield N/A
200-day MA $2.00 Market Cap 291.12M

Ocugen Inc. (OCGN) Company Bio


Ocugen, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of transformative therapies to cure blindness diseases. The company's pipeline product includes OCU200, a novel fusion protein that is in preclinical development stage for the treatment of wet AMD, diabetic retinopathy, and diabetic macular edema; OCU400 to treat retinitis pigmentosa, a group of rare genetic disorders; and OCU410, which is in preclinical development stage for the treatment of dry AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing. The company is headquartered in Malvern, Pennsylvania.


OCGN Latest News Stream


Event/Time News Detail
Loading, please wait...

OCGN Latest Social Stream


Loading social stream, please wait...

View Full OCGN Social Stream

Latest OCGN News From Around the Web

Below are the latest news stories about OCUGEN INC that investors may wish to consider to help them evaluate OCGN as an investment opportunity.

Ocugen (OCGN) Will Likely Need Large COVID Studies Going Forward

Ocugen is developing the Indian COVID vaccine Covaxin in the U.S. and has completed an immuno-bridging study with positive results. Read more on OCGN here.

Seeking Alpha | January 25, 2023

Impulsive Stock: NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO -3.61%), Ocugen, Inc. (NASDAQ:OCGN 1.61%)

NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) with the stream of -3.61% also noticed, India Ocugen, Inc. (NASDAQ:OCGN) encountered a rapid change of 1.61% in the last hour of Tuesday’s trading session. NeuroBo … The post Impulsive Stock: NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO -3.61%), Ocugen, Inc. (NASDAQ:OCGN 1.61%) appeared first on Stocks Equity .

Stock Equity | January 24, 2023

3 Under-the-Radar Stocks With 590% to 772% Upside in 2023, According to Wall Street

When the curtain closed on 2022, the ageless Dow Jones Industrial Average, widely followed S&P 500, and growth-dependent Nasdaq Composite, respectively finished lower by 9%, 19%, and 33%. It was, collectively, the worst performance for Wall Street in 14 years. This is why most analyst price targets point to upside in equities.

Yahoo | January 23, 2023

Intriguing stocks: Ocugen, Inc. (NASDAQ:OCGN -3.08%), Elanco Animal Health Incorporated (NYSE:ELAN -1.91%)

OCGN has seen its SMA50 which is now -13.03%. In looking the SMA 200 we see that the stock has seen a -40.58%. ELAN has seen its SMA50 which is … The post Intriguing stocks: Ocugen, Inc. (NASDAQ:OCGN -3.08%), Elanco Animal Health Incorporated (NYSE:ELAN -1.91%) appeared first on Stocks Equity .

Stock Equity | January 18, 2023

What Are the Chances of Ocugen Inc. (OCGN) Stagnating? Here is the INSIGHT

In the current trading session, Ocugen Inc.’s (OCGN) stock is trading at the price of $1.26, a fall of -2.69% over last night’s close. So, the stock is trading at a price that is -72.08% less than its 52-week high of $4.53 and 16.06% better than its 52-week low of $1.09. Based on the past […]

US Post News | January 17, 2023

Read More 'OCGN' Stories Here

OCGN Price Returns

1-mo 6.40%
3-mo -16.88%
6-mo -53.50%
1-year -63.36%
3-year 155.77%
5-year -99.22%
YTD 2.31%
2022 -71.43%
2021 148.63%
2020 251.92%
2019 -90.37%
2018 -95.61%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7834 seconds.